Zacks Investment ResearchThu, 09 Jul 2026 13:56:07 GMTWhy Investors Need to Take Advantage of These 2 Medical Stocks NowNTRA+2.72%
Zacks Investment ResearchWed, 01 Jul 2026 16:01:10 GMTNTRA & Aveta Partner to Advance MRD-Guided Trial in Head & Neck CancerNTRA+2.72%
Investors Business DailyMon, 29 Jun 2026 17:36:13 GMTMedical Services Name Tests For Colon Cancer. Natera Stock Hits A High.NTRA+2.72%
Zacks Investment ResearchThu, 25 Jun 2026 14:55:53 GMTNTRA's Signatera Secures PMDA Approval for MRD Testing in CRC in JapanNTRA+2.72%
Zacks Investment ResearchThu, 25 Jun 2026 13:06:05 GMTNatera (NTRA) Stock Jumps 10.7%: Will It Continue to Soar?NTRA+2.72%
BenzingaWed, 24 Jun 2026 18:14:04 GMTNatera Secures Landmark Japan Nod For Signatera In Colorectal CancerNTRA+2.72%
Investors Business DailyWed, 24 Jun 2026 16:48:52 GMTNatera Flashes A Buy Signal. Why Shares Just Leaped By Double Digits.NTRA+2.72%
Seeking AlphaSat, 13 Jun 2026 00:22:10 GMTNatera, Inc. (NTRA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptNTRA+2.72%
Zacks Investment ResearchMon, 08 Jun 2026 16:52:27 GMTNTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRCNTRA+2.72%
The Motley FoolWed, 03 Jun 2026 19:36:00 GMTHere's Billionaire Stanley Druckenmiller's Top Holding (Hint: It's Not Alphabet or Nvidia)NTRA+2.72%
Zacks Investment ResearchMon, 01 Jun 2026 18:12:12 GMTNTRA & Diakonos Partner to Use Signatera in Refractory Melanoma TrialNTRA+2.72%
24/7 Wall StreetFri, 29 May 2026 14:26:30 GMTWhy Natera Is My Favorite Stock Idea for the Rest of 2026NTRA+2.72%
Zacks Investment ResearchThu, 28 May 2026 16:06:07 GMTNatera to Launch Enhanced Panorama NIPT for Low Fetal FractionsNTRA+2.72%
Seeking AlphaWed, 27 May 2026 19:16:00 GMTBaron Health Care Fund Q1 2026 Portfolio ActivityNTRA+2.72%
Seeking AlphaWed, 27 May 2026 11:34:00 GMTNatera: A Growing Biotech, After Recent FDA Approval And Q1 Revenue ResultsNTRA+2.72%
Zacks Investment ResearchTue, 26 May 2026 16:01:04 GMTNatera Expands Austin Operations With New Sequencing FacilityNTRA+2.72%
Zacks Investment ResearchThu, 21 May 2026 17:31:14 GMTNatera's EXPAND Trial Enrollment Crosses 2,000 Patient MilestoneNTRA+2.72%
Zacks Investment ResearchMon, 18 May 2026 15:50:41 GMTNTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder CancerNTRA+2.72%
